Emergency Medicine Doctors in Lexington, NC Accepting Medicare

8 Emergency Medicine doctors found. Showing 1 - 8

Peter C Messick, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Hospital Dr, Lexington, NC 27292 Phone: 336-716-2255

Derick M Wenning, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 250 Hospital Dr, Lexington, NC 27292 Phone: 336-716-4625

Melanie Belfi, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Hospital Dr, Lexington, NC 27292 Phone: 336-716-2255

Sidney Larken Ware, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Hospital Dr, Lexington, NC 27292 Phone: 336-716-4717

David H Wagner, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 250 Hospital Dr, Lexington, NC 27292 Phone: 336-716-2255

Dr. Samuel Isaac Ritter, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Hospital Dr, Lexington, NC 27292 Phone: 336-716-4195

Laura Hays Glick, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 250 Hospital Dr, Lexington, NC 27292 Phone: 336-716-2255

Robert G Mahan, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 250 Hospital Dr, Lexington, NC 27292 Phone: 330-493-4443

News Archive

Ironwood receives FDA approval for Linzess to treat chronic idiopathic constipation, IBS

The U.S. Food and Drug Administration today approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable bowel syndrome with constipation (IBS-C) in adults.

Young hunters most likely to suffer serious injuries in tree stand-related incidents than older ones

Young hunters between the ages of 15 and 34 are the most likely to suffer serious injuries in tree stand-related incidents, say researchers at the University of Alabama at Birmingham (UAB) Center for Injury Sciences (CIS).

Transmission dynamics of SARS-CoV-2 in children: an Indian case study

Researchers have studied the primary contacts of COVID-19 positive children in India in May 2020 and found all children to be asymptomatic, and only four of the parents became positive. Although this suggests lower transmission from children, no recommendations can be made yet on school reopening.

Wockhardt receives FDA marketing approval for Lansoprazole

Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 15mg and 30 mg delayed release capsules of Lansoprazole, which is used in treatment of peptic ulcers. Lansoprazole is the generic name for the brand Prevacid, marketed in the United States by Takeda. Wockhardt is launching the product immediately.

Drug delivery device companies need to rethink their strategies to remain competitive

With increasing decentralization, new cell, gene and RNAI therapies, and a growing emphasis on patient self-care, many drug delivery device companies will need to rethink their strategies in order to remain competitive.

Read more Medical News

› Verified 8 days ago